126017-91-2Relevant academic research and scientific papers
Synthesis and Structure-Activity Relationship Studies of Anti-Inflammatory Epoxyisoprostane Analogues
Wolleb, Helene,Ogawa, Seiji,Schneider, Michael,Shemet, Andrej,Muri, Jonathan,Kopf, Manfred,Carreira, Erick M.
, p. 3014 - 3016 (2018/05/28)
The lactone derivative of the epoxyisoprostane EC is a highly effective inhibitor of the secretion of the proinflammatory cytokine IL-6. Herein, a modular synthesis of analogues is described, allowing flexible variations of the cyclic side chain of the parent lactone. A structure-activity relationship study identified a lactam analogue that retains the high activity. Furthermore, the exocyclic allylic alcohol was shown to be crucial for the observed effect.
Asymmetric induction α to nitrogen in pyrrolidines and piperidines via radical chemistry
Ewin, Richard A.,Jones, Keith,Newton, Christopher G.
, p. 1107 - 1111 (2007/10/03)
Attempts to control the stereochemistry of radical reactions at the 2-position of pyrrolidines and piperidines carrying chiral auxiliaries on the nitrogen are presented.
ASYMMETRIC SYNTHESIS OF (+)- AND (-)-CONIINES AND (-)-SEDAMINE BY DIASTEREOSELECTIVE ALKYLATION REACTION OF ETHOXYPIPERIDININE
Kiguchi, Toshiko,Nakazono, Yoko,Kotera, Sanae,Ninomiya, Ichiya,Naito, Takeaki
, p. 1525 - 1535 (2007/10/02)
Diastereoselective alkylation reaction of the chiral 6-ethoxypiperidinones (4) and (5) has been developed and successfully applied to the asymmetric synthesis of piperidine alkaloids, (+)- and (-)-coiines (11) and (12), (-)-sedamine (21), and (-)-allosedamine (22).
Stereoselective Nucleophilic Additions to the Carbon-Nitrogen Double Bond. 3. Chiral Acyliminium Ions
Polniaszek, Richard P.,Belmont, Stephen E.,Alvarez, Ramon
, p. 215 - 223 (2007/10/02)
(S)-(-)-α-Phenethylamine (3), (S)-(-)-1-(2-chlorophenyl)ethylamine (4), (S)-(-)-1-(2,6-dichlorophenyl)ethylamine (5), and (S)-(-)-1-(2,3,4,5,6-pentachlorophenyl)ethylamine (6) have been incorporated into acyliminium ions of structural type 1 and 2.Five-me
